Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram-Positive Bacteremia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002267
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Testing effectiveness (Phase 2)Study completedNCT04775953
What this trial is testing

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcal Bacteraemia
National Institute of Allergy and Infectious Diseases (NIAID) 200
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Large-scale testing (Phase 3)Study completedNCT00002101
What this trial is testing

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Pharmacia 450
Large-scale testing (Phase 3)Study completedNCT00093067
What this trial is testing

Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Who this might be right for
Bacterial EndocarditisBacteremia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)WithdrawnNCT00505258
What this trial is testing

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Who this might be right for
Bacteremia
Basilea Pharmaceutica
Not applicableLooking for participantsNCT07343167
What this trial is testing

Factors Associated With Mortality in Streptococcal Anginosus Bacteremia

Who this might be right for
Streptococcal Infections
University Hospital, Strasbourg, France 400
Not applicableStudy completedNCT03992703
What this trial is testing

Clinical Impact of Rapid AST Directly From Blood Cultures

Who this might be right for
Bacterial Infections
Fondation Hôpital Saint-Joseph 160
Testing effectiveness (Phase 2)Study completedNCT05184764
What this trial is testing

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Who this might be right for
BacteremiaStaphylococcus AureusStaphylococcus Aureus Bacteremia+2 more
Armata Pharmaceuticals, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00062647
What this trial is testing

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

Who this might be right for
Gram-Positive Bacterial Infections
Cumberland Pharmaceuticals 60
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Testing effectiveness (Phase 2)Study completedNCT00002192
What this trial is testing

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Anderson Clinical Research
Testing effectiveness (Phase 2)Study completedNCT00198302
What this trial is testing

Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

Who this might be right for
Staphylococcus Aureus Bacteremia
Bristol-Myers Squibb 60
Large-scale testing (Phase 3)Study completedNCT00001030
What this trial is testing

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,100
Not applicableStudy completedNCT00319826
What this trial is testing

Virulence Determinants in S Aureus Bacteremia

Who this might be right for
Bacteremia
Duke University 1,354
Not applicableStudy completedNCT00814151
What this trial is testing

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

Who this might be right for
BacteremiaStaphylococcal InfectionSepsis+1 more
MicroPhage, Inc. 712
Not applicableEnded earlyNCT01640886
What this trial is testing

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Who this might be right for
Bacteremia
MicroPhage, Inc. 764
Testing effectiveness (Phase 2)Looking for participantsNCT04886284
What this trial is testing

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaStaphylococcal Sepsis+1 more
Todd C. Lee MD MPH FIDSA 60
Large-scale testing (Phase 3)Study completedNCT00037050
What this trial is testing

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

Who this might be right for
Bacterial InfectionsGram-Positive Bacterial InfectionsBacteremia
Pfizer 739
Not applicableLooking for participantsNCT06958835
What this trial is testing

Linezolid Plus Standard of Care

Who this might be right for
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland 606
Next Page